RFA-JG-26-034: Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2026.
Centers for Disease Control and Prevention - ERA offered grants of up to $6.0 million to nonprofits, colleges and universities, small businesses and businesses. It expected to make one award worth $30.0 million in total. Applications closed on June 22, 2026.
From the official notice on Grants.gov, last changed May 11, 2026. Checked November 7, 2026.
- Award ceiling$6.0 million
- Total funding$30.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | May 11, 2026 |
|---|---|
| Deadline | June 22, 2026 |
| Archived by Grants.gov | June 23, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, small businesses and businesses.
All 6 applicant types the notice lists
- Public and State controlled institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Foreign organizations. A foreign organization is a public or private organization, whether nonprofit or for-profit, located in a country other than the United States and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance.
Is this a realistic fit?
- Past Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention awards averaged $1.7 million; this notice allows up to $6.0 million per award.
- Most of the program's money (51% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
This notice of funding opportunity (NOFO) supports research, implementation science, and public health evaluations to inform best practices for preventing and responding to infectious disease threats in Kenya, while strengthening local research capacity. The award recipient will conduct research, implementation science, and public health evaluations through the Kenya Medical Research Institute (KEMRI) and focus on four required priority areas:Influenza and other respiratory pathogens: Activities include surveilling high-risk groups; monitoring for human and avian influenza and other pathogens; and evaluating efficacy and use of vaccines and other treatments. Outcomes include increasing understanding of disease burden and improving vaccination strategies. Vaccine-preventable diseases: Research will assess disease burden, vaccine effectiveness, and sociocultural factors influencing immunization. Outcomes include increasing vaccine uptake and strengthening immunization systems. Drug-resistant infections: Activities include monitoring antimicrobial resistance (AMR) trends, applying novel diagnostics, and identifying drivers of resistance. Outcomes include improving mitigation strategies and global AMR preparedness. Global and emerging health threats: Research will address malaria, HIV, tuberculosis, schistosomiasis, and emerging infections. Outcomes include improving understanding of disease dynamics, intervention effectiveness, and cross-border risks. The recipient will also conduct research coordination and administration activities to manage and oversee U.S. government–funded public health research, ensure compliance with financial and ethical standards, and enhance organizational infrastructure. Outcomes include improved management and compliance with federal funding regulations. The proposed activities under this NOFO will generate evidence to guide U.S. and global preparedness, reduce disease burden and health threats in Kenya, and prevent the spread of health threats across borders.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before
From fiscal 2021 to 2025, Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention (93.326) awarded $345 million across 205 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Washington State University | Washington | 2 | $23.2 million |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 2 | $19.6 million |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 2 | $13.3 million | |
| Liverpool School of Tropical Medicine | 1 | $10.6 million | |
| California Department of Public Health | California | 1 | $10.3 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-JG-26-034 still open?
No. It closed on June 22, 2026. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya?
Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya?
Closed June 22, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $6.0 million each. About $30.0 million in total for one award.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before?
The largest recipients over five fiscal years were Washington State University, Association of Public Health Laboratories, Inc. (the), International Centre for Diarrhoeal Disease Research, Bangladesh. The program made 205 awards worth $345 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)